Screening for varices in patients with cirrhosis: Where do we stand?

American Journal of Gastroenterology

Volumn 96, Issue 3, 2001, Pages 623-624

  Chalasani, Naga ^a,b   Imperiale, Thomas F ^a  

^a INDIANA UNIVERSITY SCHOOL OF MEDICINE   (United States)

^b INDIANA UNIVERSITY   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

BETA ADRENERGIC RECEPTOR BLOCKING AGENT;

BLEEDING; CLINICAL PRACTICE; CONTROLLED STUDY; EDITORIAL; ENDOSCOPY; HUMAN; LIVER CIRRHOSIS; LIVER TRANSPLANTATION; MAJOR CLINICAL STUDY; PRACTICE GUIDELINE; PRIORITY JOURNAL; PROPHYLAXIS; SCREENING; VARICOSIS;

EID: 0035068213     PISSN: 00029270     EISSN: None     Source Type: Journal    
DOI: 10.1016/S0002-9270(00)02388-1     Document Type: Note

References (11)

1. Diagnosis and treatment of gastrointestinal bleeding secondary to portal hypertension
2. Portal hypertension and variceal bleeding: An AASLD single topic symposium
3. The use of screening and preventive therapies for gastroesophageal varices in patients referred for evaluation of orthotopic liver transplantation
4. Prevention of first variceal hemorrhage - A survey of community practice patterns
5. A novel endoscopic approach to screening for esophageal varices in cirrhotic patients
6. Predictors of large esophageal varices in patients with varices
7. Non-invasive diagnosis of esophageal varices in chronic liver diseases
8. Factors predicting the presence of esophageal and gastric varices in patients with advanced liver disease
9. A meta-analysis of endoscopic variceal ligation in primary prophylaxis of esophageal variceal bleeding in patients with cirrhosis
10. Carvedilol, a new nonselective beta-blocker with intrinsic anti alpha 1-adrenergic activity has a greater portal hypotensive effect than propranolol in patients with cirrhosis
11. Effect of losartan, an angiotensin II receptor antagonist, on portal pressure in cirrhosis